“flagship-pioneering” Archives

in
Entry Author Date Location
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More 09/25/20 National
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans 09/10/20 Boston
Generate Bio Aims to Reveal Nature’s Protein Secrets, Create New Drugs 09/10/20 Boston
Omega Therapeutics Lands $85M to Tap Into “Control Room” of Biology 07/29/20 Boston
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Sarepta Inks Codiak Deal to Explore Combining Exosomes, Muscle Meds 06/22/20 Boston
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Flagship Adds $1.1B for New Meds, More AI, & “Health Security” 04/02/20 National
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
Flagship Adds Fertility-Focused Ohana Biosciences to Biotech Family 01/27/20 Boston
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More 12/20/19 National
Ring Therapeutics Launches to Expand Gene Therapy Viral Vector Options 12/19/19 Boston
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
With $65M, Cygnal Tunes In to Nerve Signals for Drug-Making Clues 10/08/19 Boston
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further 09/23/19 Boston
Inari Reaps $89M and Eyes Global Farm Markets for Gene-Edited Seeds 08/06/19 Boston
The Finalists for the 2019 Xconomy Awards Are … 07/10/19 Boston
Xconomy Awards: Gilman & Bosley to Emcee Life Science Gala in Boston 06/20/19 Boston
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials 05/09/19 National
Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO 04/30/19 Boston
Flagship Pioneering Unveils Kintai’s Gut Approach to Treating Disease 04/16/19 Boston
Flagship Reloads With $824M For Latest Growth Capital Fund 03/20/19 Boston
Seres Lays Off 30% of Staff, CSO Leaves After Pipeline Review 02/07/19 Boston
NYCEDC Finally Puts Its NY Bio Fund to Work With $60M For HiberCell 02/07/19 New York
Kaleido Bio and Cirius Join an IPO Queue Stalled by Federal Shutdown 01/11/19 Boston
Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever 12/06/18 Boston
With CRISPR’s Help, KSQ Touts 13 Cancer Drugs and Bags Another $80M 09/28/18 Boston
Page 1 of 3 next page »